COOPER COMPANIES, INC. (COO) is held by 5 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund opening new positions, 2 funds adding, and 2 funds trimming or exiting versus the previous quarter. Insiders were net buyers over the last 90 days ($1.9M bought vs $0 sold). 1 member of Congress reported 3 purchases vs 0 sales. Latest close $60.75 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Sep 16, 2026 · Congress to Nov 16, 2026.
Longview Partners (Guernsey) · Generation Investment Management · Sustainable Growth Advisers — 5 tracked funds hold COO. See all holders.
Insiders bought on the open market (5 purchases, $1.9M) vs 0 sales ($0). Latest buy: Sep 16, 2026. Insider trading 1 member of Congress reported buying (3 purchases vs 0 sales). Latest buy: Oct 14, 2026. Politician trading
AMERICAN EXPRESS CO (AXP) · Salesforce, Inc. (CRM) · TEXAS INSTRUMENTS INC (TXN) · ALCON INC (ALC) · Warby Parker Inc. (WRBY) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Longview Partners (Guernsey) | 4.59% | 3,940,007 | ADDED (+3.1%) Q3 filed Nov 13 |
| Generation Investment Management | 3.46% | 4,968,673 | ADDED (+8.0%) Q3 filed Nov 16 |
| Sustainable Growth Advisers | 1.37% | 1,948,108 | TRIMMED (-5.2%) Q3 filed Oct 15 |
| Torray Investment Partners LLC | 0.23% | 23,286 | TRIMMED (-8.4%) Q3 filed Oct 30 |
| Oakmark Funds | 0.07% | 766,520 | NEW Q3 filed Nov 16 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -15.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 676 of 8,857 filers |
| Long-only filers among them | 674 |
| Change vs 2026 Q1 | +11 net · 631 entered · 620 exited |
| Shares reported, all filers | 207,803,332 |
| Reported value, all filers | $13.9B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Ophthalmic Goods (SIC 3851) |
| Revenue · FY2025 | $4.1B |
| Net income · FY2025 | $374.9M |
| Total assets · FY2025 | $12.4B |
| Shares outstanding | 190,155,294 |
| Market cap (at latest close) | $11.6B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Sep 3, 2026.
| Shares short · Oct 15, 2026 | 9,088,308 |
| Share of shares outstanding | 4.78% |
| Days to cover | 2.42 |
Shares short at recent settlements — Jul 31, 2026: 8.3M · Aug 14, 2026: 7.6M · Aug 31, 2026: 8.8M · Sep 15, 2026: 10.0M · Sep 30, 2026: 8.3M · Oct 15, 2026: 9.1M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Sep 3, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Sep 3, 2026.
3 insiders bought on the open market in the last 90 days (5 purchases, $1.9M), against 0 sales by 0 insiders ($0). Latest buy: Sep 16, 2026.
Source: SEC Form 4 filings. Open-market transactions only.
| Latest open-market buy | Transaction price | Price change since disclosure |
|---|---|---|
| Kurzius Lawrence Erik · 10,000 shares on Sep 16, 2026 · filed Sep 17, 2026 | $54.93 | +9.8% (close Sep 18, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Sep 18, 2026). The transaction price is what the insider paid; the price change is on closing prices (dividends excluded).
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Kurzius Lawrence Erik | Buy | 10,000 | $54.93 | $549.3K | SEC filing | |
| Sep 14, 2026 | Rosebrough Walter M Jr | Buy | 3,000 | $54.29 | $162.9K | SEC filing | |
| Sep 14, 2026 | Kurzius Lawrence Erik | Buy | 10,000 | $53.91 | $539.1K | SEC filing | |
| Sep 11, 2026 | Keel Paul A | Buy | 4,701.015 | $53.18 | $250.0K | SEC filing | |
| Sep 11, 2026 | Rosebrough Walter M Jr | Buy | 7,000 | $54.11 | $378.8K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Sep 19, 2024 | Albert G. White III | Officer | 114,992 | $12.7M | Sep 19, 2024 | SEC filing |
| Sep 10, 2024 | Agostino Ricupati | Director | 1,601 | $172.9K | Sep 10, 2024 | SEC filing |
| Sep 5, 2024 | Brian G. Andrews | Officer | 24,788 | $2.6M | Sep 5, 2024 | SEC filing |
| Sep 4, 2024 | Daniel McBride | Officer | 114,992 | $12.1M | Sep 4, 2024 | SEC filing |
| Jun 4, 2024 | Gary and Catherine Petersmeyer Trust dated November 9, 1999 | Director | 300 | $28.2K | Jun 4, 2024 | SEC filing |
| Apr 18, 2024 | Gary and Catherine Petersmeyer Trust dated November 9, 1999 | Director | 1,106 | $99.8K | Apr 18, 2024 | SEC filing |
| Apr 9, 2024 | Gary and Catherine Petersmeyer Trust dated November 9, 1999 | Director | 500 | $49.2K | Apr 9, 2024 | SEC filing |
| Apr 4, 2024 | Gary and Catherine Petersmeyer Trust dated November 9, 1999 | Director | 1,005 | $100.4K | Apr 4, 2024 | SEC filing |
| Mar 18, 2024 | Agostino Ricupati | Officer | 54,724 | $5.5M | Mar 18, 2024 | SEC filing |
| Mar 7, 2024 | Robert Weiss | Director | 241,288 | $24.0M | Mar 7, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| May 14, 2026 | Capital World Investors | SC 13G/A | 7,834,830 | 4.0% | Mar 31, 2026 | SEC filing |
| Apr 29, 2026 | Vanguard Capital Management | SC 13G | 14,664,697 | 7.5% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Nov 13, 2025 | Capital World Investors | SC 13G | 10,973,924 | 5.5% | Sep 30, 2025 | SEC filing |
| Apr 17, 2025 | BlackRock, Inc. | SC 13G/A | 14,137,034 | 7.1% | Mar 31, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
1 member of Congress reported buying (3 purchases vs 0 sales). Bought by Democrats. Latest buy: Oct 14, 2026.
Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.
Recent activity by member
| Member | Chamber | Party | Buys | Sells | Latest | Amount range |
|---|---|---|---|---|---|---|
| Cisneros, Gilbert | House | D | 3 | 0 | Oct 14, 2026 | $1,001 - $15,000 |
Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.
Industry: Ophthalmic Goods (SIC 3851). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 19 Lobbying Disclosure Act filings named this company as client, 2022–2026; most common issues: Budget/Appropriations (17), Marine/Maritime/Boating/Fisheries (2).
Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Insiders
· Insider Cluster Buying — Last 90 days: 3 or more different insiders bought on the open market
· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions
· Opportunistic Buys (Non-Routine) — Last 90 days: 2 or more insiders with no routine buying pattern bought on the open market
Politicians
· Bought by Members — Last 6 months: bought by a member of the U.S. Congress
Financial Screens
· Growth — Revenue up every year for 5 straight years
· Graham — Sound finances and a long run of profits
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
Key figures
· Growth — Latest revenue: $4.1B · 5-yr revenue CAGR: 11.0% · Straight growth years: 5
· Graham — Current ratio: 1.89 · Straight profitable years: 18 · Debt ratio: 0.50 · Latest net income: $374.9M
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 2.00 · Operating cash flow: $796.1M · Net income: $374.9M
· Insider Cluster Buying — Insiders buying: 3 · Buy txns: 5 · Buy value: $1.9M · Latest buy: Sep 16, 2026
· Insider Net Buying — Buy txns: 5 · Sell txns: 0 · Buy value: $1.9M · Latest buy: Sep 16, 2026
· Opportunistic Buys (Non-Routine) — Opportunistic buyers: 3 · Buy txns: 5 · Buy value: $1.9M · Latest buy: Sep 16, 2026
· Bought by Members — Members buying: 1 · Buy txns: 3 · Sell txns: 0 · Latest buy: Oct 14, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2025 Q4, ranked #10 of 50.
· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2026 Q2, ranked #47 of 50.
Also held by the tracked funds that hold COO — ranked by lift, the co-holding pattern described in Methodology: AMERICAN EXPRESS CO (AXP) · Salesforce, Inc. (CRM) · TEXAS INSTRUMENTS INC (TXN) · ALCON INC (ALC) · Warby Parker Inc. (WRBY) · Bausch & Lomb Corp (BLCO) · National Vision Holdings, Inc. (EYE) · THERMO FISHER SCIENTIFIC INC. (TMO).
5 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Oct 27, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 9, 2026 | 2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
| Jun 4, 2026 | 2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
AMERICAN EXPRESS CO (AXP) · Track Record: how the signals scored · Practice timing on COO
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.